UNSPSC 51131621: Apixaban

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z9Y7UWC1J. European Medicines Agency schedules Apixaban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25425. Apixaban generally arises in the molecular formula C25H25N5O4.

UNSPSC 51131621 Apixaban is a Commodity code that nominally covers the anticoagulant drug apixaban, but the most recent state and local procurement activity under this code does not reflect pharmaceutical purchasing. Sourcewell, a Minnesota local government cooperative, posted RFP #061626 in May 2026 seeking proposals for law enforcement equipment — body armor, weapons, tactical gear, communications devices, and related gear — to be made available to thousands of public entities including counties, cities, school districts, tribal governments, and nonprofit organizations across the United States and Canada. The mismatch between the code's name and the actual work being solicited suggests this code sees little relevant recent activity for apixaban itself within state and local procurement channels, or that the opportunity was miscoded.

The solicitation is being administered through Sourcewell's cooperative purchasing vehicle under Washington state law and encompasses Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington, alongside unnamed numerous other jurisdictions domestically and in Canada. Proposals are due June 16, 2026 at 3:30 p.m. Central Time through the Sourcewell Procurement Portal; vendors must register to access documents and submit questions. No set-aside designations, incumbent vendors, or award values are identified in the available documentation. This cooperative structure allows selected vendors to serve a broad public-sector customer base under standardized contracting terms established through Sourcewell's framework agreement.